SNV4818 in Participants with Advanced Solid Tumors
NCT 06736704 Brief Summary This study is testing a new medicine, SNV4818,…
Read more arrow_forwardNCT 06736704 Brief Summary This study is testing a new medicine, SNV4818,…
Read more arrow_forwardNCT 05614258 Brief Summary ADG206 is an activatable prodrug form of a…
Read more arrow_forwardNCT 05267626 Brief Summary This is a first in human, open-label, multi-center…
Read more arrow_forwardNCT 06819735 Brief Summary This is a phase 1/2, dose-escalation and cohort-expansion…
Read more arrow_forwardNCT 03947385 Brief Summary This is a Phase 1/2, multi-center, open-label basket…
Read more arrow_forwardNCT 04665206 Brief Summary This is an open-label, dose escalation and expansion…
Read more arrow_forwardNCT 04585750 Brief Summary The Phase 2 monotherapy portion of this study…
Read more arrow_forwardNCT 06003621 Brief Summary This phase II study will explore the effect…
Read more arrow_forwardNCT 05356741 Brief Summary This first-in-human (FIH) Phase 1 open-label multicenter dose-escalation…
Read more arrow_forwardNCT 04589845 Brief Summary TAPISTRY is a Phase II, global, multicenter, open-label,…
Read more arrow_forward